Acessibilidade / Reportar erro

Behavior, social competence and quality of life in Huntington's Disease

ABSTRACT:

Purpose:

investigating the behavior, the social competence and the quality of life of individuals who carry Huntington Disease.

Methods:

the sample was constituted for 30 participants, from 33 to 79 years old, divided in two groups: 15 participants in the experimental group, who were previously diagnosed with Huntington Disease and 15 participants in the comparative group, equally paired according to age and education. To assess this individuals were applied, on their caregivers, the Behavioral Inventory, constituted by the Adult Behavior Checklist and the Quality of Life Questionnaire WHOQOL - 100 were used to asses these individuals.

Results:

the individuals in the experimental group have presented statistically significant differences when compared to the control group, according to their caregivers' opinion, with high scores for internalizing factors (anxiety, depression, isolation, somatic complaints), total problems and other problems like: thinking, attention and hyperactivity problems, from the behavioral inventory. In the Quality of Life Questionnaire the experimental group has also presented statistically significant differences when compared to the control group, in all domains (physical, psychological, level of independence, social relationships, environment and religious aspects) and in most of the assessed aspects they presenting a low average of quality of life, while the control group has presented a high average.

Conclusion:

individuals with HD present behavioral, social competence and quality of life profile differentiated and with alterations, according to their caregivers, when it was related to the comparative group. Huntington's disease is limiting, progressive and also appears to be responsible for the set of behavioral change, social competence and quality of life reported by their caregivers.

KEYWORDS:
Huntington Disease; Behavior; Social Behavior; Quality of Life

RESUMO:

Objetivo:

investigar o comportamento, a competência social e a qualidade de vida de indivíduos com a Doença de Huntington (DH), segundo opinião de seus cuidadores.

Métodos:

constituíram a casuística 30 participantes, com faixa etária de 33 a 79 anos, subdivididos em dois grupos: 15 do grupo amostral (GA) diagnosticados previamente com Doença de Huntington e 15 participantes do grupo controle (GC), pareados quanto à faixa etária, gênero e classificação socioeconômica. Para avaliação destes sujeitos foram aplicados, em seus cuidadores, o Inventário Comportamental Adult Behavior Checklist e o Questionário de Qualidade de Vida WHOQOL-100.

Resultados:

na avaliação do comportamento e da competência social, os sujeitos do GA apresentaram diferença estatisticamente significante em relação ao GC, segundo opinião dos seus cuidadores, com escores elevados para fatores internalizantes (ansiedade, depressão, isolamento, queixas somáticas), totais de problemas e outros, como problemas do pensamento, atenção e hiperatividade. No questionário de qualidade de vida, para sujeitos com a DH também se evidenciou diferença estatisticamente significante em relação ao grupo controle, em todos os domínios (físico, psicológico, nível de independência, relações sociais, ambiente e aspectos religiosos) e na maioria dos subitens avaliados. O GA apresentou média baixa de qualidade de vida, enquanto o GC apresentou média alta.

Conclusão:

sujeitos com DH possuem um perfil comportamental, de competência social e qualidade de vida diferenciado e com mais alterações, em relação ao GC, segundo os cuidadores . A Doença de Huntington parece ser responsável pelo conjunto de alterações comportamentais, de competência social e de qualidade de vida, relatado pelos cuidadores.

DESCRITORES:
Doença de Huntington; Comportamento; Comportamento Social; Qualidade de Vida

Introduction

Huntington's disease - HD - (OMIM #143100; ORPHA399), described by George Huntington in 187211. OMIM (Online Mendelian Inheritance in Man). Johns Hopkins University; Inc.; 1966-2008. Disponível em: http://www.omim.org/entry/143100.
http://www.omim.org/entry/143100...
)-(33. INSTITUTO NACIONAL FRANCÊS DE SAÚDE E INVESTIGAÇÃO MÉDICA. (Coord.). Orphanet: o portal para as doenças raras e os medicamentos orfãos. 2014. Disponível em: http://www.orpha.net/consor/cgi-bin/index.php?lng=PT.
http://www.orpha.net/consor/cgi-bin/inde...
, is a neurodegenerative condition, with autosomal dominant inheritance, caused by an expansion of CAG repeat in the huntingtin gene, located on the short arm of chromosome 4 in the region 16.3. The diagnosis is performed by the presence of progressive motor and cognitive symptoms, positive family history and is confirmed by genetic testing11. OMIM (Online Mendelian Inheritance in Man). Johns Hopkins University; Inc.; 1966-2008. Disponível em: http://www.omim.org/entry/143100.
http://www.omim.org/entry/143100...
)-(33. INSTITUTO NACIONAL FRANCÊS DE SAÚDE E INVESTIGAÇÃO MÉDICA. (Coord.). Orphanet: o portal para as doenças raras e os medicamentos orfãos. 2014. Disponível em: http://www.orpha.net/consor/cgi-bin/index.php?lng=PT.
http://www.orpha.net/consor/cgi-bin/inde...
. However, Henley and colleagues (2009) showed that changes in brain volume and the neural connections may be present before the onset of symptoms44. Henley SM, Wild EJ, Hobbs NZ, Frost C, Macmanus DG, Barker RA et al. Whole-brain atrophy as a measure of progression in premanifest and early Huntington's disease. Mov. disord. 2009;24:932-6..

The prevalence of this condition is estimated at 1 per 10,000 or 20,000 individuals, but with variations in different regions and ethnic groups33. INSTITUTO NACIONAL FRANCÊS DE SAÚDE E INVESTIGAÇÃO MÉDICA. (Coord.). Orphanet: o portal para as doenças raras e os medicamentos orfãos. 2014. Disponível em: http://www.orpha.net/consor/cgi-bin/index.php?lng=PT.
http://www.orpha.net/consor/cgi-bin/inde...
.

The phenotype of HD is characterized by impairments in motor skills (e.g., tic movements, changes in gait, stiffness, etc.), cognitive skills (e.g., deficits in visual memory, auditory, verbal and attention), and behavioral changes, psychological and language11. OMIM (Online Mendelian Inheritance in Man). Johns Hopkins University; Inc.; 1966-2008. Disponível em: http://www.omim.org/entry/143100.
http://www.omim.org/entry/143100...
)-(33. INSTITUTO NACIONAL FRANCÊS DE SAÚDE E INVESTIGAÇÃO MÉDICA. (Coord.). Orphanet: o portal para as doenças raras e os medicamentos orfãos. 2014. Disponível em: http://www.orpha.net/consor/cgi-bin/index.php?lng=PT.
http://www.orpha.net/consor/cgi-bin/inde...
),(55. AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and statistical manual of mental disorders: DSM-V. American Psychiatric Publishing, 2013.). The decline of oral language, receptive and expressive level, can be triggered by two factors: neurodegeneration and motor disorders66. Azambuja MJ. Contribuição ao estudo da linguagem em indivíduos com doença de Huntington [dissertação]. São Paulo (SP): Universidade de São Paulo; 2006.),(77. Azambuja MJ, Radanovic M, Haddad MS, Adda CC, Barbosa ER, Mansur LL. Language impairment in Huntington's disease. Arq. neuropsiquiatr. 2012;70(6):410-5.).

Issues relating to behavioral changes described in DH seem to be related both to the progressive cognitive decline as the psychological changes, including depression, anxiety, irritability and apathy are the most frequent in these individuals compared with healthy individuals88. Cummings JL. Behavioral and psychiatric symptoms associated with Huntington's disease. Adv. neurolo. 1995;65:179-86.)-(1010. Thompson JC, Snowden JS, Craufurd D, Neary D. Behavior in Huntington's Disease: Dissociating Cognition-Based and Mood-Based Changes. J. neuropsychiatry clin. neurosci. 2002;14:37-43..

Regarding quality of life, there are reports of suicide justified by depression and physical dependence caused by the impact of symptoms on daily activities1111. Di Maio L, Squitieri F, Napolitano G, Campanella G, Trofatter JA, Conneally PM. Suicide risk in Huntington's disease. J. medical. genet. 1993;30:293-5.),(1212. Helder DI, Kaptein AA, Van Kempen GM, Van Houwelingen JC, Roos RA. Impact of Huntington's disease on quality of life. Mov. disord. 2001;16(2):325-30.. Therefore, the DH impairs the mental health of individuals and may be observed suffering and emotional stress among family throughout the course of the disease1313. Williams JK, Skirton H, Paulsen JS, Tripp-Reimer T, Jarmon L, Mcgonigal KM, et al. The emotional experiences of family carers in Huntington disease. J. adv. nurs. Epub 2009;65(4):789-98.),(1414. Banaszkiewicz K, Sitek EJ, Rudzinska M, Soltan W, Slawek J, Szczudlik A. Huntington's disease from the patient, caregiver and physician's perspectives: three sides of the same coin? J. neural. transm. 2012;119(11):1361-5..

Although literature has studies on the behavioral aspects related to DH, few studies are conducted on the behavioral profile, social competence and quality of life of these individuals88. Cummings JL. Behavioral and psychiatric symptoms associated with Huntington's disease. Adv. neurolo. 1995;65:179-86.),(1010. Thompson JC, Snowden JS, Craufurd D, Neary D. Behavior in Huntington's Disease: Dissociating Cognition-Based and Mood-Based Changes. J. neuropsychiatry clin. neurosci. 2002;14:37-43.),(1212. Helder DI, Kaptein AA, Van Kempen GM, Van Houwelingen JC, Roos RA. Impact of Huntington's disease on quality of life. Mov. disord. 2001;16(2):325-30.),(1515. Kingma EM, Van Duijn E, Timman R, Mast RC, Roos RA. Behavioural problems in Huntington's disease using the Problem Behaviours Assessment. Gen. hosp. psychiatr. 2008;30(2):155-61.)-(1717. Carlozzi NE, Tulsky DS. Identification of health-related quality of life (HRQOL) issues relevant to individuals with Huntington disease. J. health psychol. 2013;18(2):212-25..

Therefore, this study aimed to investigate the behavior, social competence and the quality of life of individuals with Huntington's disease, according to the opinion of their caregivers.

Methods

The study was approved by the Research Ethics Committee of UNESP - Marilia, under the protocol number 0710/2013, and participants signed the Informed Consent (IC).

The participants were 30 individuals of both genders, with age between 33 and 79 years. The individuals were divided into two subgroups: sample group (SG) consisting of 15 individuals with a diagnosis of Huntington's disease; and control group (CG), consisting of 15 i individuals without diagnosis or symptoms and negative family history for HD.

For inclusion of SG, were considered: diagnosis of Huntington's disease and signing the Informed Consent. Longer as exclusion criteria were considered: not confirmed diagnosis of HD, comorbidity with other disorders and individuals who refused to participate in the study.

Behavioral assessment and social competence

To investigate the behavior and social competence (e.g., aggressive behavior, anxiety / depression, social problems, etc.), it was applied the Behavioral Inventory consisted of the Adult Behavior Checklist (ABCL)1818. Achenbach TM, Rescorla LA. Manual for the ASEBA School-Age Forms & Profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth & Families, 2001. in caregivers (i.e., family members or not) of individuals to the HD.

This inventory consists of 126 items that list a number of desirable or destructive behaviors which the applicant must select the frequency in which these behaviors occur. It was attributed to each item / issue "zero" when it is not true or does not occur; "1", if it is sometimes real or does not occur frequently; and "2", it is very true or often occurs1818. Achenbach TM, Rescorla LA. Manual for the ASEBA School-Age Forms & Profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth & Families, 2001..

The items presented on ABCL comprise 14 individual scales corresponding to different individual's behavior problems: (1) internalizing - anxiety, depression, anxious/depressed, isolation, somatic complaints, somatic problems, withdrawn; (2) externalizing - aggressive behavior, rule-breaking behavior, intrusive; (3) Others- antisocial personality problems, thought problems, attention/hyperactivity problems.

Evaluation of quality of life

The Quality of Life Questionnaire WHOQOL-1001919. WHOQOL Group. WHOQOL User Manual. Programme on mental health, 1998. Disponível em: http://www.who.int/.../who_qol_user_manual_98.pdf.
http://www.who.int/.../who_qol_user_manu...
lists a number of issues relating to the family or caregiver vision on quality of life and health of the individual, and for each respondent marks the frequency with which these problems occur.

For this, the WHOQOL-1001919. WHOQOL Group. WHOQOL User Manual. Programme on mental health, 1998. Disponível em: http://www.who.int/.../who_qol_user_manual_98.pdf.
http://www.who.int/.../who_qol_user_manu...
evaluates six domains, consisting of 24 sub-items, as follows: (1) Domain 1 - physical, composed of sub-items "pain and discomfort", "Energy and fatigue" and "Sleep and rest"; (2) Domain 2 - psychological, consisting of sub-items "Positive feelings", "Thinking, learning, memory and concentration", "Self-esteem", "Body image and appearance" and "Negative feelings"; (3) Domain 3 - level of independence, composed of sub-items "mobility", "Activities of daily life", "drug addiction or treatment" and "Ability to work"; (4) Domain 4 - social relations "personal relations", " social support " and "sexual activity"; (5) Domain 5 - environment, consisting of the sub-items "Physical security and protection," "Home environment", "financial resources", "Health care and social: availability and quality," "opportunity to acquire new information and skills" "Participation in and opportunities for recreation / leisure", "Physical environment: pollution / noise / traffic / climate" and "Transport"; and (6) Domain 6 - spiritual aspects / religion / personal beliefs, consisting of sub-items "Spirituality / religion / personal beliefs."

Figure 1 presents the selection phase, according to criteria of inclusion and exclusion, as well as the assessment procedures used in this study.

Figure 1:
Sample selection Stages and evaluation methods

Data analysis

The analysis of data collected by the Behavior Inventory was performed using the Assessment Data Manager Software (ADM), which is the program developed for analysis of this procedure2020. Achenbach TM, Rescorla LA, Maruish ME. The Achenbach System of Empirically Based Assessment (ASEBA) for ages 1.5 to 18 years. In: Maruish ME, editor. The Use of Psychological Testing for Treatment Planning and Outcomes Assessment. New Jersey: Taylor & Francis; 2004. P.179-213..

In addition to this analysis, the data collected by the instruments were submitted to descriptive and comparative statistical analysis using the Statistical Package for Social Sciences software (SPSS), in its version 21.0.

Results

Behavioral inventory of Adult Behavior checklist (ABCL)

The results obtained by this behavioral Inventory ABCL were analyzed according to the score obtained for each of the eight scales isolated and subsequently grouped into Internalizing, Externalizing and Total Problems Scales.

The attitudes that compose such scales are presented in Table 1 in an isolated manner, which also presents the comparison between SG and CG in all ABCL scales.

Table 1:
Comparison of results in behavioral scales ABCL in the sample and comparison groups, according to opinion of their caregivers

After analyzing the isolated behaviors, it was carried out analysis of the set of behaviors grouped to form the scales. Figure 2 demonstrates the performance profile of the individuals of the SG and CG regarding Internalizing Scale. Figure 3 shows the same profile in relation to Externalizing Scale and in Figure 4 compared to the Total Problems Scale.

Figure 2:
Comparison of the results of ABCL between the sample group and the control group, according to the internalizing factors

Figure 3:
Comparison of the results of ABCL between the sample group and the control group, according to externalizing factors

Figure 4:
Comparison of the results of ABCL between the sample group and the control group by total problems

Figure 5 shows the change in average score of considering the age as a determining variable. It is observed that the range of CG score (47 to 63 points) has lower gap when compared with the SG (56 to 93 points). Therefore, advancing age does not seem to be decisive for issues related to behavior.

Figure 5:
Comparison of the average overall score of the sample group and control group considering the age variable in ABCL behavioral Inventory

WHOQOL questionnaire

In the replies of the caregivers to the WHOQOL-100 questionnaire it was noted that there were differences in average score of between the SG and CG groups in all domains (Figure 6).

Figure 6:
Scoring average distribution of the sample group and control group, according to the domains of the questionnaire of quality of life WHOQOL

Table 2 presents data comparing SG and CG for all sub classification that compose the questionnaire on quality of life, where it appears that only three sub-items had no significant difference when comparing the groups.

Table 2:
Comparison of sub-items of the WHOQOL quality of life questionnaire between individuals with and without Huntington's disease, according to the opinion of their caregivers

The average score of for the quality of life due to age was drawn, and as a result it is observed that the change in score for SG was greater than for the CG. In this regard the increase in age was not decisive for the increase in score (Figure 7).

Figure 7:
Comparison of average overall score of the sample group and control group considering the age variable in the WHOQOL

Discussion

Using the data obtained from the Behavioral Inventory, it was observed that the SG when compared to the CG showed statistically significant differences in internalizing factors (Table 1, Figure 2) and total problems (Table 1; Figure 4), suggesting that the behavioral profile with changes involves not only the individual but also the environment where he is inserted, consequently showing losses in his social relation1111. Di Maio L, Squitieri F, Napolitano G, Campanella G, Trofatter JA, Conneally PM. Suicide risk in Huntington's disease. J. medical. genet. 1993;30:293-5.)-(1414. Banaszkiewicz K, Sitek EJ, Rudzinska M, Soltan W, Slawek J, Szczudlik A. Huntington's disease from the patient, caregiver and physician's perspectives: three sides of the same coin? J. neural. transm. 2012;119(11):1361-5..

Among the behavioral characteristics investigated, there is high incidence of social isolation, avoidance, somatic complaints, somatic problems and depressive feelings, the latter is a finding that may also be observed in other studies and identified as responsible for the high rate of suicide in individuals with HD1515. Kingma EM, Van Duijn E, Timman R, Mast RC, Roos RA. Behavioural problems in Huntington's disease using the Problem Behaviours Assessment. Gen. hosp. psychiatr. 2008;30(2):155-61.),(2121. Rosenblatt A. Neuropsychiatry of Huntington's disease. Dialogues clin. neurosci. 2007;9(2):191-7.. Anxiety was also one of the changes often mentioned by caregivers and is pointed as a major cause of problems in interpersonal relationships of individuals with HD and their caregivers99. Duijin E, Kingma EM, Mast RC. Psychopathology in Verified Huntington's Disease Gene Carriers. J. neuropsychiatry clin. neurosci. 2007;19:441-8.),(1515. Kingma EM, Van Duijn E, Timman R, Mast RC, Roos RA. Behavioural problems in Huntington's disease using the Problem Behaviours Assessment. Gen. hosp. psychiatr. 2008;30(2):155-61.),(2222. Paulsen JS, Ready RE, Hamilton JM, Mega M, Cummings J. Neuropsychiatric aspects of Huntington's disease. J. neurol., neurosurg. psychiatry. 2001;71:310-4.),(2323. Paulsen JS, Nehl C, Hoth KF, Kanz JE, Benjamin M, Conybeare R et al. Depression and stages of Huntington's disease. J. neuropsychiatry clin. neurosci. 2005;17(4):496-502..

Behavioral changes such as aggression (attitudes of mood swings, irritability and verbal or physical attacks on other people) was mentioned by 50% of the caregivers in this study. This data can be justified, according to literature, as a neuropsychiatric symptom unrelated to cognitive or motor deficits and may have as a predictor anxiety1616. Craufurd D, Thompson JC, Snowden JS. Behavioral changes in Huntington Disease. Neuropsychiatry neuropsychol. behav. neurol. 2001;14(4):219-26.), (2323. Paulsen JS, Nehl C, Hoth KF, Kanz JE, Benjamin M, Conybeare R et al. Depression and stages of Huntington's disease. J. neuropsychiatry clin. neurosci. 2005;17(4):496-502.)-(2525. Nimmagadda SR, Agrawal N, Worrall-Davies A, Markova I, Rickards H. Determinants of irritability in Huntington's disease. Acta neuropsychiatr. 2011;23(6):309-14..

In relation to the data found in the WHOQOL, it is emphasized that there is no cut-off points for scores, so the higher the score the better the quality of life of individuals. According to the results, it appears that individuals with HD, when compared to healthy individuals, they had lower scores in all domains and global scope. These data are in agreement with findings of previous studies that identified in this respect, negative influences of the disease since the beginning of its manifestations, according to family / caregivers1414. Banaszkiewicz K, Sitek EJ, Rudzinska M, Soltan W, Slawek J, Szczudlik A. Huntington's disease from the patient, caregiver and physician's perspectives: three sides of the same coin? J. neural. transm. 2012;119(11):1361-5.),(1717. Carlozzi NE, Tulsky DS. Identification of health-related quality of life (HRQOL) issues relevant to individuals with Huntington disease. J. health psychol. 2013;18(2):212-25.),(2626. Aubeeluck AV, Buchanan H, Stupple EJ. All the burden on all the carers': exploring quality of life with family caregivers of Huntington's disease patients. Qual. life res. 2012;21(8):1425-35..

Considering the different domains of assessment of quality of life, it is emphasized that the SG had a significant gap when compared to CG, showing that the level of dependency can be seen as one of the factors that negatively impact the quality of life. The findings of this study confirm the literature findings, which register the presence of physical changes and functional impairment of the individual with HD as dependency factors, according to the progression of the disease, affecting also their quality of life. Therefore, they are responsible for overload of physical and mental work of family / caregiver1414. Banaszkiewicz K, Sitek EJ, Rudzinska M, Soltan W, Slawek J, Szczudlik A. Huntington's disease from the patient, caregiver and physician's perspectives: three sides of the same coin? J. neural. transm. 2012;119(11):1361-5.),(2626. Aubeeluck AV, Buchanan H, Stupple EJ. All the burden on all the carers': exploring quality of life with family caregivers of Huntington's disease patients. Qual. life res. 2012;21(8):1425-35..

Given the data presented, it can be suggested that HD causes significant behavioral changes in social competence and quality of life of individuals regardless of age (Figures 5 and 7), according to the caregivers. It is noteworthy that the data corroborate those described in study with symptomatic individuals and in risk of the development of the disease when it was observed that the emotional health and social participation are important factors in quality of life, mentioned even before the physical health1717. Carlozzi NE, Tulsky DS. Identification of health-related quality of life (HRQOL) issues relevant to individuals with Huntington disease. J. health psychol. 2013;18(2):212-25..

Conclusion

Individuals with HD have a behavioral profile of social competence and quality of life distinguished and with more changes, according to their caregivers when compared with the control group. Huntington's disease is limiting, progressive and appears to be responsible for the set of behavioral, social and quality of life changes as reported by their caregivers. Complementary and cross-sectional studies could answer important questions about the impact of this disease, in relation to the advance of symptoms, behavioral profile, social competence and quality of life, according to the viewpoint of the individual himself with HD.

Acknowledgment

To the "Association Huntington Brazil" for their support in conducting this research and to all participants.

Referências

  • 1
    OMIM (Online Mendelian Inheritance in Man). Johns Hopkins University; Inc.; 1966-2008. Disponível em: http://www.omim.org/entry/143100.
    » http://www.omim.org/entry/143100
  • 2
    Roos ACR. Huntington's disease: a clinical review. Orphanet j. rare dis. 2010;5:1-8.
  • 3
    INSTITUTO NACIONAL FRANCÊS DE SAÚDE E INVESTIGAÇÃO MÉDICA. (Coord.). Orphanet: o portal para as doenças raras e os medicamentos orfãos. 2014. Disponível em: http://www.orpha.net/consor/cgi-bin/index.php?lng=PT.
    » http://www.orpha.net/consor/cgi-bin/index.php?lng=PT
  • 4
    Henley SM, Wild EJ, Hobbs NZ, Frost C, Macmanus DG, Barker RA et al. Whole-brain atrophy as a measure of progression in premanifest and early Huntington's disease. Mov. disord. 2009;24:932-6.
  • 5
    AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and statistical manual of mental disorders: DSM-V. American Psychiatric Publishing, 2013.
  • 6
    Azambuja MJ. Contribuição ao estudo da linguagem em indivíduos com doença de Huntington [dissertação]. São Paulo (SP): Universidade de São Paulo; 2006.
  • 7
    Azambuja MJ, Radanovic M, Haddad MS, Adda CC, Barbosa ER, Mansur LL. Language impairment in Huntington's disease. Arq. neuropsiquiatr. 2012;70(6):410-5.
  • 8
    Cummings JL. Behavioral and psychiatric symptoms associated with Huntington's disease. Adv. neurolo. 1995;65:179-86.
  • 9
    Duijin E, Kingma EM, Mast RC. Psychopathology in Verified Huntington's Disease Gene Carriers. J. neuropsychiatry clin. neurosci. 2007;19:441-8.
  • 10
    Thompson JC, Snowden JS, Craufurd D, Neary D. Behavior in Huntington's Disease: Dissociating Cognition-Based and Mood-Based Changes. J. neuropsychiatry clin. neurosci. 2002;14:37-43.
  • 11
    Di Maio L, Squitieri F, Napolitano G, Campanella G, Trofatter JA, Conneally PM. Suicide risk in Huntington's disease. J. medical. genet. 1993;30:293-5.
  • 12
    Helder DI, Kaptein AA, Van Kempen GM, Van Houwelingen JC, Roos RA. Impact of Huntington's disease on quality of life. Mov. disord. 2001;16(2):325-30.
  • 13
    Williams JK, Skirton H, Paulsen JS, Tripp-Reimer T, Jarmon L, Mcgonigal KM, et al. The emotional experiences of family carers in Huntington disease. J. adv. nurs. Epub 2009;65(4):789-98.
  • 14
    Banaszkiewicz K, Sitek EJ, Rudzinska M, Soltan W, Slawek J, Szczudlik A. Huntington's disease from the patient, caregiver and physician's perspectives: three sides of the same coin? J. neural. transm. 2012;119(11):1361-5.
  • 15
    Kingma EM, Van Duijn E, Timman R, Mast RC, Roos RA. Behavioural problems in Huntington's disease using the Problem Behaviours Assessment. Gen. hosp. psychiatr. 2008;30(2):155-61.
  • 16
    Craufurd D, Thompson JC, Snowden JS. Behavioral changes in Huntington Disease. Neuropsychiatry neuropsychol. behav. neurol. 2001;14(4):219-26.
  • 17
    Carlozzi NE, Tulsky DS. Identification of health-related quality of life (HRQOL) issues relevant to individuals with Huntington disease. J. health psychol. 2013;18(2):212-25.
  • 18
    Achenbach TM, Rescorla LA. Manual for the ASEBA School-Age Forms & Profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth & Families, 2001.
  • 19
    WHOQOL Group. WHOQOL User Manual. Programme on mental health, 1998. Disponível em: http://www.who.int/.../who_qol_user_manual_98.pdf.
    » http://www.who.int/.../who_qol_user_manual_98.pdf
  • 20
    Achenbach TM, Rescorla LA, Maruish ME. The Achenbach System of Empirically Based Assessment (ASEBA) for ages 1.5 to 18 years. In: Maruish ME, editor. The Use of Psychological Testing for Treatment Planning and Outcomes Assessment. New Jersey: Taylor & Francis; 2004. P.179-213.
  • 21
    Rosenblatt A. Neuropsychiatry of Huntington's disease. Dialogues clin. neurosci. 2007;9(2):191-7.
  • 22
    Paulsen JS, Ready RE, Hamilton JM, Mega M, Cummings J. Neuropsychiatric aspects of Huntington's disease. J. neurol., neurosurg. psychiatry. 2001;71:310-4.
  • 23
    Paulsen JS, Nehl C, Hoth KF, Kanz JE, Benjamin M, Conybeare R et al. Depression and stages of Huntington's disease. J. neuropsychiatry clin. neurosci. 2005;17(4):496-502.
  • 24
    Reedeker N, Bouwens JA, Giltay EJ, Le Mair SE, Roos RA, Mast RCVD et al. Irritability in Huntington's disease. Psychiatry res. 2012;200(2):813-8.
  • 25
    Nimmagadda SR, Agrawal N, Worrall-Davies A, Markova I, Rickards H. Determinants of irritability in Huntington's disease. Acta neuropsychiatr. 2011;23(6):309-14.
  • 26
    Aubeeluck AV, Buchanan H, Stupple EJ. All the burden on all the carers': exploring quality of life with family caregivers of Huntington's disease patients. Qual. life res. 2012;21(8):1425-35.

Publication Dates

  • Publication in this collection
    Nov-Dec 2015

History

  • Received
    19 Dec 2014
  • Accepted
    13 Feb 2015
ABRAMO Associação Brasileira de Motricidade Orofacial Rua Uruguaiana, 516, Cep 13026-001 Campinas SP Brasil, Tel.: +55 19 3254-0342 - São Paulo - SP - Brazil
E-mail: revistacefac@cefac.br